244 related articles for article (PubMed ID: 16778119)
1. Inflammatory response to acute myocardial infarction augments neointimal hyperplasia after vascular injury in a remote artery.
Takaoka M; Uemura S; Kawata H; Imagawa K; Takeda Y; Nakatani K; Naya N; Horii M; Yamano S; Miyamoto Y; Yoshimasa Y; Saito Y
Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):2083-9. PubMed ID: 16778119
[TBL] [Abstract][Full Text] [Related]
2. Deficiency of tumour necrosis factor-alpha and interferon-gamma in bone marrow cells synergistically inhibits neointimal formation following vascular injury.
Murayama H; Takahashi M; Takamoto M; Shiba Y; Ise H; Koyama J; Tagawa Y; Iwakura Y; Ikeda U
Cardiovasc Res; 2008 Nov; 80(2):175-80. PubMed ID: 18791204
[TBL] [Abstract][Full Text] [Related]
3. Temporal and spatial characterization of cellular constituents during neointimal hyperplasia after vascular injury: Potential contribution of bone-marrow-derived progenitors to arterial remodeling.
Shoji M; Sata M; Fukuda D; Tanaka K; Sato T; Iso Y; Shibata M; Suzuki H; Koba S; Geshi E; Katagiri T
Cardiovasc Pathol; 2004; 13(6):306-12. PubMed ID: 15556776
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietin-mobilized endothelial progenitors enhance reendothelialization via Akt-endothelial nitric oxide synthase activation and prevent neointimal hyperplasia.
Urao N; Okigaki M; Yamada H; Aadachi Y; Matsuno K; Matsui A; Matsunaga S; Tateishi K; Nomura T; Takahashi T; Tatsumi T; Matsubara H
Circ Res; 2006 Jun; 98(11):1405-13. PubMed ID: 16645141
[TBL] [Abstract][Full Text] [Related]
5. Central role of endogenous Toll-like receptor-2 activation in regulating inflammation, reactive oxygen species production, and subsequent neointimal formation after vascular injury.
Shishido T; Nozaki N; Takahashi H; Arimoto T; Niizeki T; Koyama Y; Abe J; Takeishi Y; Kubota I
Biochem Biophys Res Commun; 2006 Jul; 345(4):1446-53. PubMed ID: 16730663
[TBL] [Abstract][Full Text] [Related]
6. Thalidomide as a potent inhibitor of neointimal hyperplasia after balloon injury in rat carotid artery.
Park SJ; Kim HS; Yang HM; Park KW; Youn SW; Jeon SI; Kim DH; Koo BK; Chae IH; Choi DJ; Oh BH; Lee MM; Park YB
Arterioscler Thromb Vasc Biol; 2004 May; 24(5):885-91. PubMed ID: 14988093
[TBL] [Abstract][Full Text] [Related]
7. Granulocyte colony-stimulating factor (G-CSF) accelerates reendothelialization and reduces neointimal formation after vascular injury in mice.
Yoshioka T; Takahashi M; Shiba Y; Suzuki C; Morimoto H; Izawa A; Ise H; Ikeda U
Cardiovasc Res; 2006 Apr; 70(1):61-9. PubMed ID: 16448633
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II receptor blocker inhibits neointimal hyperplasia through regulation of smooth muscle-like progenitor cells.
Yamada T; Kondo T; Numaguchi Y; Tsuzuki M; Matsubara T; Manabe I; Sata M; Nagai R; Murohara T
Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2363-9. PubMed ID: 17717297
[TBL] [Abstract][Full Text] [Related]
9. Rosiglitazone facilitates angiogenic progenitor cell differentiation toward endothelial lineage: a new paradigm in glitazone pleiotropy.
Wang CH; Ciliberti N; Li SH; Szmitko PE; Weisel RD; Fedak PW; Al-Omran M; Cherng WJ; Li RK; Stanford WL; Verma S
Circulation; 2004 Mar; 109(11):1392-400. PubMed ID: 14993120
[TBL] [Abstract][Full Text] [Related]
10. Critical role of bone marrow apoptosis-associated speck-like protein, an inflammasome adaptor molecule, in neointimal formation after vascular injury in mice.
Yajima N; Takahashi M; Morimoto H; Shiba Y; Takahashi Y; Masumoto J; Ise H; Sagara J; Nakayama J; Taniguchi S; Ikeda U
Circulation; 2008 Jun; 117(24):3079-87. PubMed ID: 18541743
[TBL] [Abstract][Full Text] [Related]
11. Stem cell factor deficiency is vasculoprotective: unraveling a new therapeutic potential of imatinib mesylate.
Wang CH; Anderson N; Li SH; Szmitko PE; Cherng WJ; Fedak PW; Fazel S; Li RK; Yau TM; Weisel RD; Stanford WL; Verma S
Circ Res; 2006 Sep; 99(6):617-25. PubMed ID: 16931795
[TBL] [Abstract][Full Text] [Related]
12. Deficiency of interleukin-1 receptor antagonist promotes neointimal formation after injury.
Isoda K; Shiigai M; Ishigami N; Matsuki T; Horai R; Nishikawa K; Kusuhara M; Nishida Y; Iwakura Y; Ohsuzu F
Circulation; 2003 Aug; 108(5):516-8. PubMed ID: 12874179
[TBL] [Abstract][Full Text] [Related]
13. Diverse contribution of bone marrow-derived cells to vascular remodeling associated with pulmonary arterial hypertension and arterial neointimal formation.
Sahara M; Sata M; Morita T; Nakamura K; Hirata Y; Nagai R
Circulation; 2007 Jan; 115(4):509-17. PubMed ID: 17242277
[TBL] [Abstract][Full Text] [Related]
14. Vein graft neointimal hyperplasia is exacerbated by tumor necrosis factor receptor-1 signaling in graft-intrinsic cells.
Zhang L; Peppel K; Brian L; Chien L; Freedman NJ
Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2277-83. PubMed ID: 15486311
[TBL] [Abstract][Full Text] [Related]
15. Stem cell factor attenuates vascular smooth muscle apoptosis and increases intimal hyperplasia after vascular injury.
Wang CH; Verma S; Hsieh IC; Hung A; Cheng TT; Wang SY; Liu YC; Stanford WL; Weisel RD; Li RK; Cherng WJ
Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):540-7. PubMed ID: 17204664
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow AT1 augments neointima formation by promoting mobilization of smooth muscle progenitors via platelet-derived SDF-1{alpha}.
Yokoi H; Yamada H; Tsubakimoto Y; Takata H; Kawahito H; Kishida S; Kato T; Matsui A; Hirai H; Ashihara E; Maekawa T; Iwai M; Horiuchi M; Ikeda K; Takahashi T; Okigaki M; Matsubara H
Arterioscler Thromb Vasc Biol; 2010 Jan; 30(1):60-7. PubMed ID: 19834109
[TBL] [Abstract][Full Text] [Related]
17. Reduced connexin43 expression limits neointima formation after balloon distension injury in hypercholesterolemic mice.
Chadjichristos CE; Matter CM; Roth I; Sutter E; Pelli G; Lüscher TF; Chanson M; Kwak BR
Circulation; 2006 Jun; 113(24):2835-43. PubMed ID: 16769907
[TBL] [Abstract][Full Text] [Related]
18. Role of bone marrow-derived cells in the genetic control of restenosis.
Langwieser N; Schwarz JB; Reichenbächer C; Stemmer B; Massberg S; Langwieser NN; Zohlnhöfer D
Arterioscler Thromb Vasc Biol; 2009 Oct; 29(10):1551-7. PubMed ID: 19644054
[TBL] [Abstract][Full Text] [Related]
19. Late outgrowth endothelial cells derived from Wharton jelly in human umbilical cord reduce neointimal formation after vascular injury: involvement of pigment epithelium-derived factor.
Wang SH; Lin SJ; Chen YH; Lin FY; Shih JC; Wu CC; Wu HL; Chen YL
Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):816-22. PubMed ID: 19342598
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-1 receptor antagonist originating from bone marrowderived cells and non-bone marrow-derived cells helps to suppress arterial inflammation and reduce neointimal formation after injury.
Isoda K; Akita K; Isobe S; Niida T; Adachi T; Iwakura Y; Daida H
J Atheroscler Thromb; 2014; 21(11):1208-18. PubMed ID: 25223697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
